NeoGenomics, Inc.
- NEO
- NASDAQ
- Medical - Diagnostics & Research
- Cancer Diagnostics/Testing
- Genomic Lab Services
$16.58
Today +0.95%Quote Oct 20, 2026, 02:10 PM UTC
−17.53%over the last month
Max drawdown −19.8%From 1-month high −17.5%3 months +13.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About NeoGenomics
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
2,500
Founded
2001
Market value
$2.16B
Quote Oct 20
Floor
$15.86
4.3% below price
Resistance
$16.65
0.5% above price
Price vs analyst targets
30 analysts
Lowest target
$19.00Highest target
$28.00
$19.00Highest target
$28.00
- Price $16.58
- Average target $23.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 42% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about NEOPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free